PRISM BioLab Co Ltd (206A)

Currency in JPY
183.00
+1.00(+0.55%)
Delayed Data·
206A Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Earnings results expected tomorrow
206A is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
181.00185.00
52 wk Range
175.00657.00
Key Statistics
Bid/Ask
182.00 / 183.00
Prev. Close
182
Open
182
Day's Range
181-185
52 wk Range
175-657
Volume
43.6K
Average Volume (3m)
122.01K
1-Year Change
-62.16%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
206A Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

PRISM BioLab Co Ltd Company Profile

PRISM BioLab Co.,LTD, a biotechnology company, discovers and develops small molecule inhibitors of protein-protein interaction targets utilizing proprietary PepMetics technology for treating patients suffering from cancer, autoimmune, fibrosis, and other diseases. It develops E7386 targeting CBP/beta-catenin, which is in Phase II clinical trial for the treatment of cancer; and PRI724 targeting CBP/beta-catenin that is in Phase II clinical trial for treating cirrhosis. The company has license agreements with Eisai Co., Ltd. and Ohara Pharmaceuticals Co.,Ltd. for the development of drugs for treating cancer and liver diseases. PRISM BioLab Co.,LTD was founded in 2006 and is based in Fujisawa, Japan.

Compare 206A to Peers and Sector

Metrics to compare
206A
Peers
Sector
Relationship
P/E Ratio
0.0x12.8x−0.5x
PEG Ratio
0.000.080.00
Price/Book
0.0x1.7x2.6x
Price / LTM Sales
0.0x2.6x3.3x
Upside (Analyst Target)
0.0%−7.1%41.6%
Fair Value Upside
Unlock−1.5%5.9%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-7.76 / --
Revenue / Forecast
93.00M / --
EPS Revisions
Last 90 days

206A Income Statement

FAQ

What Stock Exchange Does PRISM BioLab Trade On?

PRISM BioLab is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for PRISM BioLab?

The stock symbol for PRISM BioLab is "206A."

What Is the PRISM BioLab Market Cap?

As of today, PRISM BioLab market cap is 6.54B.

What Is PRISM BioLab's Earnings Per Share (TTM)?

The PRISM BioLab EPS (TTM) is 0.00.

When Is the Next PRISM BioLab Earnings Date?

PRISM BioLab will release its next earnings report on 13 Aug 2025.

From a Technical Analysis Perspective, Is 206A a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has PRISM BioLab Stock Split?

PRISM BioLab has split 0 times.

How Many Employees Does PRISM BioLab Have?

PRISM BioLab has 0 employees.

What is the current trading status of PRISM BioLab (206A)?

As of 13 Aug 2025, PRISM BioLab (206A) is trading at a price of 183.00, with a previous close of 182.00. The stock has fluctuated within a day range of 181.00 to 185.00, while its 52-week range spans from 175.00 to 657.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.